Peiyong Guan

11PUBLICATIONS
68CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersLiquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 02, 2026
Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer.

|Apr 01, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Jing Han Hong, Chern Han Yong, Hong Lee Heng

|Oct 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma.

Cheng Huang, Yan Gao, Jianfeng Chen

|Aug 09, 2024
Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability.

Peiyong Guan, Jianfeng Chen, Chengqiang Mo

|Feb 24, 2024
Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches.

Divya Khosla, Shagun Misra, Pek Lim Chu

|Apr 24, 2023
PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.

Xiaosai Yao, Jing Han Hong, Amrita M Nargund

Pageof 2

Frequent Collaborators

6 joint publications

Bin Tean Teh

6 joint publications

Jason Yongsheng Chan

4 joint publications

Jing Han Hong

4 joint publications

Jing Tan